(Q81300604)
Statements
Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial (English)
Philip J Mease
Eric M Ruderman
Serge D Steinfeld
Ernest H S Choy
John T Sharp
Peter A Ory
Renee J Perdok
Mark A Weinberg
Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group
1 October 2005